U.S. Stock News

Hub Group (HUBG) recently informed investors that it will miss the SEC deadline for its upcoming 10-Q filing, a disclosure that often prompts closer attention to potential operational, financial, or accounting questions. See our latest analysis for Hub Group. The 10 Q delay comes after a sharp pullback in Hub Group’s share price, which has fallen 15.69% over the past week and 21.32% over 30 days. However, the 1 year total shareholder return of 15.03% still reflects earlier gains. Recent...

Global Partners LP recently reported its second-quarter 2026 results, with sales of US$6,792.09 million and net income of US$65.11 million, alongside meaningfully higher basic and diluted earnings per share from continuing operations than a year earlier. For the first half of 2026, the partnership generated US$12,113.89 million in sales and US$129.85 million in net income, highlighting a sharp improvement in profitability versus the prior-year period. We’ll now examine how this strong jump...

In the second quarter of 2026, Arcus Biosciences reported revenue of US$41 million versus US$160 million a year earlier, with a net loss of US$91 million and basic and diluted loss per share of US$0.72. For the first half of 2026, revenue fell to US$58 million from US$188 million while net loss widened to US$219 million, even as the company forecast full-year GAAP revenue of US$65 million to US$75 million. With Arcus now projecting full-year 2026 revenue of just US$65 million to US$75...

People Incorporated recently reported second-quarter 2026 results showing US$436.74 million in sales and a sharp jump in net income to US$506.85 million, while also confirming new CEO Neil Vogel and CFO Timothy Quinn appointments, updating full-year operating income guidance to US$15 million–US$80 million, and completing a multi-year buyback of 15,516,658 shares for US$699.27 million. These developments, alongside activist investor Yakira Capital’s public call to abandon the remaining MGM...

Acushnet Holdings Corp. reported past second-quarter 2026 results with sales of US$819.95 million and net income of US$124.83 million, alongside higher earnings per share versus the prior year. Alongside raising its 2026 sales outlook, completing a long-running US$1.04 billion share buyback and affirming its quarterly dividend highlighted management’s confidence and ongoing capital returns. Next, we’ll examine how Acushnet’s upgraded full-year guidance and solid first-half performance affect...

MSCI Inc. recently launched a consultation on revising its Global Investable Market Indexes to exclude certain “non-operating companies” that behave more like investment funds, using new financial ratio screens focused on operating assets and cash flows. This proposal could reshape index eligibility for niche holdings such as Bitcoin treasury and uranium vehicles, influencing how institutional and ETF investors gain exposure to these themes through MSCI-branded benchmarks. We’ll now examine...

Genco Shipping & Trading (GNK) has become a focal point for investors after Diana Shipping withdrew its takeover offer, citing disagreement with the Genco board over acceptable deal pricing and shareholder value. See our latest analysis for Genco Shipping & Trading. The latest takeover twists sit against a strong run in Genco Shipping & Trading’s stock, with a 42.84% year to date share price return and a 70.51% total shareholder return over one year. Meanwhile, multi year total shareholder...

In August 2026, Cellebrite DI Ltd. reported half-year 2026 results, lowered its full-year revenue outlook to US$555 million–US$561 million with 17%–18% annual growth, and announced a planned CEO transition in which Shiven Ramji succeeded Thomas E. Hogan and joined the board. These moves, combined with softer profitability and delayed large government contracts, have prompted investor scrutiny over execution, disclosure practices, and the pace of converting AI and cloud investments into more...

TJX Companies (TJX) shares have been moving as investors react to fresh earnings expectations. Wall Street projects quarterly earnings of $1.18 per share on revenue of $15.14 billion, with attention on segment performance and comparable store sales. See our latest analysis for TJX Companies. At a share price of $152.11, TJX Companies has seen short term share price pressure with a 7 day share price return down 5.73%. However, the 1 year total shareholder return of 16.10% and 5 year total...

The recent court decision around de minimis tariffs has quietly reshuffled the playing field for everyday consumer products. Higher costs on low value imports could squeeze some retailers, yet may hand more pricing power to certain domestic manufacturers. For investors, this opens a fresh angle on U.S. made goods exposure that many portfolios may miss. This article walks through three stocks tied to this story and explains why their setup deserves attention now. The stocks outlined below are...

Cencora, Inc. recently reported third-quarter 2026 results, with sales of US$84.75 billion and net income of US$763.52 million, while also declaring a US$0.60 quarterly dividend and amending its credit facilities to expand liquidity and extend maturities. The combination of strong earnings growth across the first nine months of 2026, continued share repurchases totaling 7,950,265 shares for US$2.00 billion, and expanded multi-currency credit capacity highlights how Cencora is using both its...

Rising global government bond yields are pushing investors to rethink where real growth might come from next. When safer assets offer more income, attention often shifts to companies that insiders know well and still choose to back with their own capital. That mix of growth potential and high insider ownership is rare. This article highlights three stocks from the Fast Growing Stocks With High Insider Ownership screener that fit that profile. The stocks covered below are just a starting...

Prudential Financial (PRU) is back in focus after reporting second quarter 2026 net income of US$985 million and completing a US$498.51 million share repurchase program, a combination many investors watch closely. See our latest analysis for Prudential Financial. Prudential Financial’s recent earnings update and completed US$498.51 million buyback have coincided with rising momentum, with a 90 day share price return of 21.51% and a 1 year total shareholder return of 24.55% from a US$125.13...

Spectrum Brands Holdings (SPB) is back in focus after Q3 2026 results combined a record quarter in Home & Garden with a sizeable intangible asset impairment that pushed the company into a net loss. See our latest analysis for Spectrum Brands Holdings. At a share price of $89.93, Spectrum Brands Holdings has seen a 49.78% year to date share price return and a 63.52% total shareholder return over the past year. This performance suggests momentum has been building as investors weigh the Q3...

Brookfield Wealth Solutions Ltd. reported past second-quarter 2026 results showing revenue rising to US$4,217 million from US$3,037 million a year earlier, while net income fell to US$143 million from US$501 million. For the first half of 2026, revenue edged up to US$5,873 million from US$5,655 million, but results swung from net income of US$175 million to a net loss of US$466 million, even as the company affirmed a quarterly US$0.07 per-share return of capital payable on September 29,...

VinFast Auto Ltd. reported that in July 2026 it delivered 21,781 electric vehicles in Vietnam, a 21% increase from June, bringing preliminary year-to-date domestic deliveries to 137,697 and reinforcing its leadership in the local automotive market. This step-up in domestic volumes highlights how VinFast’s home-market strength in Vietnam is becoming an increasingly important pillar of its broader electric vehicle ambitions. We’ll now examine how this stronger July delivery performance in...

MeiraGTx Holdings plc reported past second-quarter 2026 results showing revenue rising to US$321.43 million from US$3.69 million a year earlier, with net income improving to US$160.72 million from a US$38.8 million loss, alongside key leadership hires and a US$12.96 million shelf registration for 1,000,000 ordinary shares tied to an employee share plan. By pairing a shift to profitability with senior executives experienced in taking complex therapies through approval and commercialization,...

Rising long term US and European bond yields are putting a higher price on labor and capital. This makes every extra unit of productivity more valuable. That is where the robotics and automation stocks in this screener come in. They sit at the heart of the physical AI shift that aims to do more with fewer workers. This article highlights three standout robotics stocks from the screener. The three robotics and automation stocks below are just a starting sample, since the full screen surfaced...

Champion Homes (SKY) drew attention after first quarter 2026 earnings reported sales of US$710.23 million and net income of US$49.16 million, along with a US$50 million increase in its share repurchase authorization. See our latest analysis for Champion Homes. Champion Homes shares are trading at US$94.53 after a 42.62% 90 day share price return and a 29.19% total shareholder return over the past year, suggesting momentum has strengthened around the mixed earnings and expanded buyback...

In the past quarter, Krystal Biotech, Inc. reported Q2 2026 net income of US$54.77 million, with basic earnings per share from continuing operations of US$1.85, up from US$38.33 million and US$1.33 a year earlier. Over the first half of 2026, net income rose to US$110.70 million and higher per-share earnings underscored the earnings power of Vyjuvek alongside an advancing gene therapy pipeline. We’ll now examine how this stronger profitability profile, anchored by Vyjuvek’s contribution,...

In August 2026, Doximity, Inc. reported first-quarter revenue of US$156.62 million, up from US$145.91 million a year earlier, while net income fell to US$24.32 million from US$53.32 million, and the company issued guidance calling for second-quarter revenue of US$170–171 million and full-year revenue of US$671–681 million. Management highlighted surging adoption of its AI-powered clinical tools, independent validation of its Ask product’s safety and accuracy, and growing enterprise AI client...

In August 2026, Celcuity Inc. reported a wider Q2 net loss of US$78.86 million and higher basic loss per share, while securing FDA approval and a preferred Category 1 NCCN guideline recommendation for Revtopik in HR-positive, HER2-negative advanced breast cancer. Alongside the deeper losses, the combination of strong Phase 3 efficacy data and rapid guideline endorsement for Revtopik materially reshapes how Celcuity’s pipeline can translate into future commercial activity. We’ll now examine...

In August 2026, Applied Industrial Technologies reported higher fourth-quarter and full-year sales and net income, while issuing new fiscal 2027 guidance that calls for earnings per share of US$11.65 to US$12.15 and total sales growth of 4.0% to 6.5% excluding future M&A and buybacks. Management also highlighted nearly US$2.00 billion of balance sheet capacity and an active acquisition pipeline, signaling an intention to use M&A to enhance scale, broaden its technical solutions platform and...

Cogent Biosciences, Inc. reported past earnings results for the second quarter and first half of 2026, with second-quarter net loss of US$96.41 million compared with US$73.53 million a year earlier, and six-month net loss of US$193.76 million versus US$145.52 million. The widening losses highlight ongoing cost and funding pressures that may influence how investors assess the company’s progress toward its research and development goals. Next, we’ll examine how Cogent Biosciences’ higher net...